By Brian T. Horowitz
During the COVID-19 pandemic, Piedmont Healthcare, an 11-hospital health system in Georgia, pivoted to use its Piedmont Now app to coordinate vaccine distribution. The health system is now looking at how to integrate more virtual care options into the mobile app.
read more
By Fraiser Kansteiner
As Moderna continues to beef up its COVID-19 vaccine production work, it's drawing on some serious muscle from South Korea. The biotech has unveiled a pact with Samsung Biologics that will see the CDMO crank out "hundreds of millions" of doses from its facilities in Incheon.
read more
By Andrea Park
Singapore’s Ministry of Health will use the BreFence Go system to test incoming travelers at the Tuas Checkpoint between Singapore and Malaysia, where a negative test is required to enter the city-state.
read more
By Paige Minemyer
There was a significant increase in pharmacy fraud and abuse under the pandemic, analysts at OptumRx say.
read more
By Kevin Dunleavy
In its battle with Merck for next-gen pneumococcal vaccine supremacy, Pfizer is attempting to gain an advantage as it kicks off a test of co-administered Prevnar 20 and COVID-19 booster shots in adults age 65 and older.
read more
By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner
Pfizer has started a co-administration study of its next-gen pneumococcal candidate with a COVID-19 booster shot. Plus, AstraZeneca's CEO again defended his company's pandemic response.
read more
By Dave Muoio
The nonprofit maintained its strong momentum from late last year, posting another quarter of gains in spite of mixed volumes and mounting costs.
read more
By Fraiser Kansteiner
As COVID-19 vaccines and therapeutics reach the public, the companies involved in the pandemic fight have laid out some eye-popping pay packages for their chief executives. One in particular, coming in at more than $135 million, will likely set a benchmark for years to come. Meanwhile, pandemic players weren't the only ones to reward their helmsmen handsomely in 2020.
read more
